Genomics Inform.  2019 Dec;17(4):e38. 10.5808/GI.2019.17.4.e38.

DNA methylation: a cause and consequence of type 2 diabetes

Affiliations
  • 1Personalized Genomic Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Korea. mirang@kribb.re.kr
  • 2Department of Functional Genomics, University of Science and Technology (UST), Daejeon 34141, Korea.

Abstract

DNA methylation is a relatively stable epigenetic modification that can regulate and stabilize gene expression patterns and hence establish cell identity. Because metabolic intermediates are key factors of DNA methylation and demethylation, perturbations in metabolic homeostasis can trigger alterations in cell-specific patterns of DNA methylation and contribute to disease development, including type 2 diabetes (T2D). During the past decade, genome-wide DNA methylation studies of T2D have expanded our knowledge of the molecular mechanisms underlying T2D. This review summarizes case-control studies of the DNA methylome of T2D and discusses DNA methylation as both a cause and consequence of T2D. Therefore, DNA methylation has potential as a promising T2D biomarker that can be applied to the development of therapeutic strategies for T2D.

Keyword

diabetes; DNA methylation; epigenetics

MeSH Terms

Case-Control Studies
DNA Methylation*
DNA*
Epigenomics
Gene Expression
Homeostasis
DNA
Full Text Links
  • GNI
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr